Neurology
RSSArticles
-
Vitamins C and E Antioxidants Linked to Lower Parkinson’s Risk
These brain-boosting nutrients are packed into certain fruits and vegetables.
-
Pregnant Women with High Blood Pressure Might Experience Memory Problems
These study participants struggled with thinking and recall exercises 15 years after the pregnancy.
-
Why Does This WCT Change Its Shape?
Imagine there was no history for the ECG shown in the figure. How would one interpret this tracing?
-
Remdesivir Injection and Baricitinib Tablets
Baricitinib/remdesivir should be used to treat suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients ≥ age 2 years who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.
-
Using Sacubitril/Valsartan to Treat Heart Failure with Preserved Ejection Fraction
An analysis of renal outcomes in the PARAGON-HF trial revealed sacubitril/valsartan slows progression of kidney disease in patients with heart failure with preserved ejection fraction compared to valsartan alone.
-
Virtual Visits and Antibiotic Prescribing
Compared to in-person visits, virtual visits were associated with improved antibiotic prescribing practices for women with uncomplicated urinary tract infections.
-
Vegan Diets May Cause More Fractures
Living as a vegan or vegetarian is a choice and can benefit one’s health. However, clinicians should educate patients about potential risks, including bone fractures. Appropriate supplementation might prevent these complications.
-
Honey, Can You Stop Coughing?
Since there is little to offer those with upper respiratory infections, honey represents a low-risk, inexpensive, and easily accessible alternative that seems reasonable to suggest to patients.
-
A Mobile Interventional Stroke Team (MIST) Shows Promise in Performing Rapid Thrombectomy
Since 2015, when multiple international trials were reported showing clear benefit for mechanical thrombectomy in patients with large vessel occlusions, this treatment has been the standard of care. However, the speed of treatment remains paramount for good outcomes, and different models have been developed around the world in different geographic settings.
-
Ticagrelor, a New Antiplatelet Agent, Shows Promise in Secondary Prevention of Ischemic Stroke
Ticagrelor is an antiplatelet agent that works by reversibly binding to P2Y12 adenosine diphosphate receptors on platelets, similar to the mechanism of action of clopidogrel. However, it is a direct-acting drug, and not a pro-drug, and does not need to be enzymatically converted to be active, like clopidogrel.